Table 2 Clinical characteristics and cancer-specific survival in patients with inoperable gastro-oesophageal cancer: multivariate survival analysis
Patients ( n =258) | Hazard ratio (95% CI) | P -value | |
|---|---|---|---|
Age (<65/65–74/>75 years) | 91/64/103 | 1.22 (1.02–1.46) | 0.032 |
Sex (male/female) | 166/92 | 1.07 (0.80–1.45) | 0.642 |
Tumour type (adenocarcinoma/squamous) | 187/71 | 1.28 (0.87–1.89) | 0.210 |
Tumour site (oesophagus/gastric) | 142/116 | 1.36 (0.96–1.92) | 0.087 |
TNM stage (I/II/III/IV) | 29/27/64/138 | 1.55 (1.30–1.83) | <0.001 |
GPS (0/1/2) | 92/121/45 | 1.51 (1.22–1.86) | <0.001 |
Alkaline phosphatase (U l−1) (Tertiles 1/2/3) | 85/85/84 | 1.10 (0.92–1.32) | 0.300 |
Treatment (active/supportive) | 195/63 | 2.53 (1.80–3.56) | <0.001 |
